Marsico Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-909,633
Closed -$133M 100
2017
Q3
$133M Buy
909,633
+138,490
+18% +$18.9M 5.32% 6
2017
Q2
$100M Sell
771,143
-112,859
-13% -$13.8M 4.19% 8
2017
Q1
$110M Sell
884,002
-39,822
-4% -$4.77M 4.76% 7
2016
Q4
$107M Buy
923,824
+644,489
+231% +$71.8M 4.73% 7
2016
Q3
$29.2M Sell
279,335
-54,279
-16% -$5.87M 1.09% 26
2016
Q2
$32.9M Sell
333,614
-363,922
-52% -$37.6M 1.14% 23
2016
Q1
$69.8M Sell
697,536
-432,175
-38% -$44.5M 2.07% 16
2015
Q4
$135M Sell
1,129,711
-541,392
-32% -$62.6M 2.39% 18
2015
Q3
$181M Buy
1,671,103
+120,271
+8% +$14.9M 1.88% 23
2015
Q2
$179M Sell
1,550,832
-497,504
-24% -$56.9M 1.59% 24
2015
Q1
$236M Sell
2,048,336
-57,574
-3% -$6.88M 1.99% 21
2014
Q4
$236M Sell
2,105,910
-8,713
-0.4% -$919K 1.89% 23
2014
Q3
$200M Sell
2,114,623
-2,364,872
-53% -$213M 1.57% 26
2014
Q2
$385M Buy
4,479,495
+264,405
+6% +$20.1M 2.79% 16
2014
Q1
$294M Sell
4,215,090
-931,546
-18% -$73.8M 2.12% 18
2013
Q4
$435M Sell
5,146,636
-19,232
-0.4% -$1.52M 3.08% 9
2013
Q3
$398M Buy
5,165,868
+4,886,758
+1,751% +$342M 2.94% 10
2013
Q2
$16.3M Buy
+279,110
New +$16.8M 0.1% 79

Other funds holding CELG

Marsico Capital Management's CELG Position: Q4 2017 in Review

Marsico Capital Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 909,633 shares — an estimated $133M sold.

Marsico Capital Management first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $435M in Q4 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Marsico Capital Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Marsico Capital Management sold 909,633 Celgene Corp shares in Q4 2017, an estimated $133M.
  • Marsico Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Marsico Capital Management's Celgene Corp position peaked at $435M in Q4 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Marsico Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.